Sysmex (OTCMKTS:SSMXY) Sets New 12-Month Low - Time to Sell?

Key Points

• Sysmex Corporation's share price has reached a new 52-week low of $11.79, closing at $12.23 after trading, reflecting concerns over its recent financial performance.
• The company reported a net loss in EPS of $0.05 for the last quarter, missing analyst expectations of $0.12, and revenue also fell short at $717.09 million compared to estimates of $807.27 million.
• Analysts from Zacks Research have upgraded Sysmex's rating from "strong sell" to "hold," indicating a potential stabilization in investor sentiment despite current challenges.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report)'s share price hit a new 52-week low during trading on Wednesday . The stock traded as low as $11.79 and last traded at $12.23, with a volume of 807 shares changing hands. The stock had previously closed at $12.51.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Sysmex from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 14th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of "Hold".

Sysmex Stock Down 1.7%

The firm has a market cap of $7.74 billion, a price-to-earnings ratio of 24.59 and a beta of 1.16. The business's 50 day moving average price is $13.31 and its 200 day moving average price is $16.09. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.49 and a current ratio of 3.37.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.12 by ($0.07). The firm had revenue of $717.09 million for the quarter, compared to analyst estimates of $807.27 million. Sysmex had a return on equity of 10.20% and a net margin of 9.35%. On average, equities analysts forecast that Sysmex Corporation ADR will post 0.57 EPS for the current year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.